Goodbye to analog

microscope slides used in a laboratory setting, likely for pathology or histology
00:00 min00:00 min

Goodbye to analog

The Briefing

Digital medicine has seen a major boom in the past five years with the development of powerful artificial intelligence tools, allowing researchers to digitize analog processes and speed up everything from drug development to clinical research. One project at Novartis is focusing on creating tools to digitize disease analysis, helping set new standards in pathology.

Published on 22/03/2021

More

Thanks for reading Live.Magazine

Stay connected by subscribing to our newsletter

Subscribe

By submitting your email, you consent to Novartis AG collecting and processing your email data for Novartis internal use, in accordance with our privacy policy, and by protected technical means.